BD bone marrow aspiration
Taiwan·Risk Class 2·BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION 2200, INC.·Registered Jan 13, 2005 – Jan 13, 2025Expired- Analysis ID
- d07fc8fc83686e4927b1ceec7bebf07e
- Customs Code
- DHA00601100405
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology and urology
- Import Information
- import
- Registration Date
- Jan 13, 2005
- Expiry Date
- Jan 13, 2025
Top companies providing products similar to "BD bone marrow aspiration"
Recently registered similar products
Access comprehensive regulatory information for BD bone marrow aspiration in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d07fc8fc83686e4927b1ceec7bebf07e and manufactured by BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION 2200, INC.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION D.R. 203, LTD., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.